The complement system has been shown to play a pathogenic role in only
a small number of muscle diseases. A complement-induced microangiopat
hy is important in dermatomyositis and in the rare disorder, necrotizi
ng myopathy with pipestem capillaries, Recent studies demonstrate the
reversibility of micovascular damage in dermatomyositis by intravenous
immune globulin which appears to intercept the assembly and depositio
n of membrane attack complex. In myasthenia gravis, complement-mediate
d lysis directed at the acetylcholine receptor leads to a cascade of e
vents reducing the number of receptors, simplifying the complex archit
ecture of the junctional folds and decreasing the available surface fo
r the insertion of new receptors. The newest condition in which a role
for complement has been demonstrated is X-linked vacuolated myopathy.
The condition is of interest because membrane attack complex deposits
result in shedding of complement-laden membrane fragments in contrast
to a cytolytic process as the consequence of assembly of the terminal
complement components.